CRISPR-Cas system

Deep research

Generated by just research-trait; source: research/traits/genomics/crispr_cas_system-deep-research-falcon.md

# Curation-focused research report: CRISPR–Cas system

## Trait record and scope

- **Trait label:** CRISPR-Cas system
- **Trait identifier:** `traitmech:000094`
- **Category / kind / status:** GENOMICS / CLASS / REVIEWED
- **Parent:** `METPO:1000188`
- **Recommended operational definition:** possession of a genomic CRISPR array and cognate CRISPR-associated machinery that together encode sequence-specific memory of invasive nucleic acids and can support spacer acquisition and/or crRNA-guided interference.

The canonical phenotype is a **heritable, sequence-specific adaptive-defense capacity** in bacteria or archaea. Foreign nucleic-acid fragments are incorporated as spacers, the array is expressed and processed into crRNAs, and crRNA-containing effector complexes recognize complementary protospacers and destroy or otherwise suppress the matching mobile genetic element. The three stages are **adaptation, expression/crRNA biogenesis, and interference**. A 2024 experimental paper states that during expression “the CRISPR array is transcribed into a precursor crRNA,” after which mature crRNAs guide Cas proteins to degrade foreign nucleic acids. (chi2024rnaprocessingby pages 1-2)

### Inclusion rule

Curate the positive trait when genomic evidence supports both:

1. a recognizable CRISPR repeat–spacer array; and
2. a sufficiently complete cognate `cas` module for an accepted subtype, or direct experimental evidence of adaptive acquisition or interference.

The locus normally includes a CRISPR array and `cas` genes. Cas1–Cas2 constitute the conserved adaptation module, whereas subtype-specific effectors perform crRNA maturation, target recognition, and interference. (hidalgocantabrana2020characterizationandapplications pages 1-6)

### Boundary cases

- **CRISPR array alone:** An orphan array demonstrates repeat–spacer architecture or historical exposure, not necessarily a functional CRISPR-Cas immune system. Do not infer the complete trait without cognate machinery or functional evidence.
- **Isolated `cas` genes:** A lone `cas1`, `cas2`, nuclease, or CRISPR-associated accessory gene is insufficient. Cas proteins can occur in incomplete, mobile, or functionally repurposed modules.
- **Degenerate/incomplete loci:** Record as `uncertain` or a separate “CRISPR-Cas locus remnant” concept. In *Lactobacillus crispatus*, complete and degenerate systems co-occurred, illustrating why an array hit alone is not decisive. (hidalgocantabrana2019genomeeditingusing pages 1-2)
- **Interference-only systems:** Some systems can use spacers acquired by another locus or lack a canonical acquisition module. They may still express a natural CRISPR-Cas defense phenotype, but the graph must not require Cas1–Cas2 for every subtype instance.
- **Inactive or suppressed systems:** Genomic possession is distinct from activity under a particular assay. H-NS-like regulation, absent induction, mismatched spacers, or anti-CRISPRs can make a genetically present system phenotypically silent.
- **CRISPRi, genome editing, diagnostics, and gene drives:** These are engineered uses derived from CRISPR-Cas, not the microbial possession trait itself. Keep them outside the core causal graph except as applications.
- **Nearby defense traits:** Restriction–modification, abortive infection, toxin–antitoxin, BREX, DISARM, and innate surface resistance are separate defense mechanisms. CRISPR-Cas is distinguished by stored spacer information and RNA-guided sequence recognition.
- **“CRISPR array” as a synonym:** This is narrower than the complete trait and should preferably be treated as a component rather than an exact synonym.

## Current classification and quantitative context

The evidence base used by the existing record classifies CRISPR-Cas into **two classes and six types**, with Class 1 systems using multisubunit effectors and Class 2 systems using a single multidomain effector. Type I, III, and IV belong to Class 1; Types II, V, and VI to Class 2. A 2020 authoritative review reported 44 subtypes at that time. (hidalgocantabrana2020characterizationandapplications pages 1-6)

Prevalence depends on databases, assembly quality, and the criterion used. A 2024 review estimated CRISPR-Cas in approximately **50% of bacteria and 90% of archaea**; a 2024 primary article used “over 40% of bacteria and nearly all archaea.” These figures should be treated as approximate rather than intrinsic trait constants. (allemailem2024currentupdatesof pages 1-3, chouzheng2024acriiia1isa pages 1-2)

Subtype distribution is highly nonuniform. Type I systems are described as the most abundant natural class, while one structural analysis estimated Type III systems at approximately **25% of all CRISPR systems**; the latter value came from a preprint-derived source and should not be curated as a fixed prevalence. (hidalgocantabrana2020characterizationandapplications pages 1-6, paraan2023thestructureof pages 1-4)

A recent example of strong taxonomic enrichment is *L. crispatus*: CRISPR loci occurred in **51/52 genomes (98%)**, compared with approximately **63%** reported for the broader *Lactobacillus* genus. This is a species-sampling result, not a universal prevalence estimate. (hidalgocantabrana2019genomeeditingusing pages 1-2)

## Candidate nodes

### Trait, structures, and sequence entities

| Candidate node | Role | Suggested grounding |
|---|---|---|
| CRISPR-Cas system | Target trait | `traitmech:000094` |
| CRISPR array | Genomic memory locus of repeats and spacers | Label-only; Sequence Ontology mapping should be verified before use |
| CRISPR direct repeat | Repeated structural element | Label-only |
| spacer | Acquired memory sequence | Label-only |
| protospacer | Matching sequence in foreign nucleic acid | Label-only |
| protospacer-adjacent motif (PAM) | Recognition/acquisition determinant in many DNA-targeting systems | Label-only |
| leader sequence | Array-proximal regulatory/integration region | Label-only |
| foreign/mobile genetic element | Source and target of spacers | `GO:0032196` transposition is **not** an equivalent; retain label-only or use a suitable mobile-genetic-element ontology term after verification |
| bacteriophage | Major selective/experimental factor | `NCBITaxon:10239` is Viruses and is too broad; use taxon-specific IDs when known |
| plasmid | Foreign DNA target/source | `GO:0005727` (extrachromosomal circular DNA) may be useful only where biologically appropriate |

### Nucleic acids and chemicals

Showing the first 60 of 264 lines of findings; the linked file also carries the run's front matter and the prompt it was given — read the full report.